Vancomycin MIC as a predictor of outcome in MRSA bacteraemia in the UK context

Effect of Reduced Vancomycin Susceptibility on Clinical and Economic Outcomes in Staphylococcus aureus Bacteremia

(2012) Jennifer H. Han et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureusbacteremia

(2011) Hitoshi Honda et al.   BMC INFECTIOUS DISEASES

Impact of Vancomycin Exposure on Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets

(2011) R. Kullar et al.   CLINICAL INFECTIOUS DISEASES

BSAC standardized disc susceptibility testing method (version 10)

(2011) J. M. Andrews et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia

(2011) C. J. Walraven et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

(2011) Natasha E. Holmes et al.   JOURNAL OF INFECTIOUS DISEASES

Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?

(2011) T. L. Holland et al.   JOURNAL OF INFECTIOUS DISEASES

A Field Guide to Pandemic, Epidemic and Sporadic Clones of Methicillin-Resistant Staphylococcus aureus

(2011) Stefan Monecke et al.   PLoS One

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) bacteremia in Taiwan: Mortality analyses and the impact of vancomycin, MIC = 2 mg/L, by the broth microdilution method

(2010) Jiun-Ling Wang et al.   BMC INFECTIOUS DISEASES

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

(2010) Y. K. Yoon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Outcomes with daptomycin in the treatment of Staphylococcus aureus infections with a range of vancomycin MICs

(2010) J. A. Crompton et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin

(2009) James Price et al.   CLINICAL INFECTIOUS DISEASES

Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales

(2009) M. J. Ellington et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007

(2009) M. J. Ellington et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years

(2009) A. C. Musta et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

(2008) M. Rybak et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin

(2008) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections

(2008) Donald I. Hsu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

BSAC standardized disc susceptibility testing method (version 7)

(2008) J. M. Andrews et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Influence of Vancomycin Minimum Inhibitory Concentration on the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

(2007) A. Soriano et al.   CLINICAL INFECTIOUS DISEASES